These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cytokines in autoimmune disorders. Feldmann M; Brennan FM; Maini R Int Rev Immunol; 1998; 17(1-4):217-28. PubMed ID: 9914949 [TBL] [Abstract][Full Text] [Related]
5. The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis. Andreakos E; Sacre S; Foxwell BM; Feldmann M Front Biosci; 2005 Sep; 10():2478-88. PubMed ID: 15970510 [TBL] [Abstract][Full Text] [Related]
6. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Williams RO; Paleolog E; Feldmann M Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis. Feldmann M; Brennan FM; Williams RO; Cope AP; Gibbons DL; Katsikis PD; Maini RN Prog Growth Factor Res; 1992; 4(3):247-55. PubMed ID: 1307491 [TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy. Alam J; Jantan I; Bukhari SNA Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758 [TBL] [Abstract][Full Text] [Related]
9. Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases. Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A Genes Immun; 2013 Mar; 14(2):67-82. PubMed ID: 23190644 [TBL] [Abstract][Full Text] [Related]
10. [Anti-cytokine therapy: present status and future perspectives in nephrology]. Panichi V; Paoletti S G Ital Nefrol; 2004; 21(5):446-53. PubMed ID: 15547876 [TBL] [Abstract][Full Text] [Related]
11. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Feldmann M; Maini RN Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034 [TBL] [Abstract][Full Text] [Related]
12. Anticytokine therapy--new approach to the treatment of autoimmune and cytokine-disturbance diseases. Skurkovich SV; Skurkovich B; Kelly JA Med Hypotheses; 2002 Dec; 59(6):770-80. PubMed ID: 12445524 [TBL] [Abstract][Full Text] [Related]
13. Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases. Gadina M; Gazaniga N; Vian L; Furumoto Y J Autoimmun; 2017 Dec; 85():20-31. PubMed ID: 28676205 [TBL] [Abstract][Full Text] [Related]
14. Anticytokine therapy impacting on B cells in autoimmune diseases. Daridon C; Burmester GR; Dörner T Curr Opin Rheumatol; 2009 May; 21(3):205-10. PubMed ID: 19346949 [TBL] [Abstract][Full Text] [Related]
15. New approaches to the therapy of autoimmune diseases: rheumatoid arthritis as a paradigm. Moreland LW; Heck LW; Sullivan W; Pratt PW; Koopman WJ Am J Med Sci; 1993 Jan; 305(1):40-51. PubMed ID: 8416681 [TBL] [Abstract][Full Text] [Related]
16. Targeting cytokine signaling in autoimmunity: back to the future and beyond. Hirahara K; Schwartz D; Gadina M; Kanno Y; O'Shea JJ Curr Opin Immunol; 2016 Dec; 43():89-97. PubMed ID: 27821272 [TBL] [Abstract][Full Text] [Related]
18. Anti-cytokine vaccination: a new biotherapy of autoimmunity? Semerano L; Assier E; Boissier MC Autoimmun Rev; 2012 Sep; 11(11):785-6. PubMed ID: 22349621 [TBL] [Abstract][Full Text] [Related]
19. Current strategies for the treatment of autoimmune diseases. Rosato E; Pisarri S; Salsano F J Biol Regul Homeost Agents; 2010; 24(3):251-9. PubMed ID: 20846473 [TBL] [Abstract][Full Text] [Related]
20. New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Peifer C; Wagner G; Laufer S Curr Top Med Chem; 2006; 6(2):113-49. PubMed ID: 16454763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]